543271 Stock Overview
Engages in the life science products and solutions in India, the United States, Europe, China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Jubilant Ingrevia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹716.80 |
| 52 Week High | ₹836.95 |
| 52 Week Low | ₹409.80 |
| Beta | 0.41 |
| 11 Month Change | -7.53% |
| 3 Month Change | 11.97% |
| 1 Year Change | 72.89% |
| 33 Year Change | 12.69% |
| 5 Year Change | n/a |
| Change since IPO | 164.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543271 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 9.3% | 1.1% | 0.004% |
| 1Y | 72.9% | 23.6% | 37.7% |
Return vs Industry: 543271 exceeded the Indian Chemicals industry which returned 23.6% over the past year.
Return vs Market: 543271 exceeded the Indian Market which returned 37.7% over the past year.
Price Volatility
| 543271 volatility | |
|---|---|
| 543271 Average Weekly Movement | 8.2% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 543271's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 543271's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 2,283 | Deepak Jain | jubilantingrevia.com |
Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions.
Jubilant Ingrevia Limited Fundamentals Summary
| 543271 fundamental statistics | |
|---|---|
| Market cap | ₹113.24b |
| Earnings (TTM) | ₹1.76b |
| Revenue (TTM) | ₹41.10b |
64.5x
P/E Ratio2.8x
P/S RatioIs 543271 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543271 income statement (TTM) | |
|---|---|
| Revenue | ₹41.10b |
| Cost of Revenue | ₹20.89b |
| Gross Profit | ₹20.21b |
| Other Expenses | ₹18.46b |
| Earnings | ₹1.76b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 28, 2025
| Earnings per share (EPS) | 11.11 |
| Gross Margin | 49.18% |
| Net Profit Margin | 4.27% |
| Debt/Equity Ratio | 25.3% |
How did 543271 perform over the long term?
See historical performance and comparison